FDA says study overestimated non-compliance with data-reporting laws

May 1, 2012

The US Food and Drug Administration (FDA) and National Institutes of Health have disputed charges that sponsors are under-reporting clinical-trial results. The letters to Congress, obtained by Nature under the Freedom of Information Act, come in response to questions raised after a study in the British Medical Journal (BMJ), reported that, in 2009, only 22% of trial sponsors posted their results within one year of completion, as the law requires. (Nature News)

Recommended Reading